TL;DR — Chilibeck et al. 2015
Chilibeck and colleagues published a 12-month randomized controlled trial showing that creatine supplementation combined with resistance training attenuated the age-related loss of bone mineral density at the femoral neck in postmenopausal women.
The creatine group maintained bone density while the placebo group experienced the expected decline.
This study provides important evidence for creatine’s role in bone health beyond its established muscle benefits.
Background
Osteoporosis is a major concern for postmenopausal women, with bone mineral density declining rapidly after menopause due to estrogen withdrawal.
Resistance training helps maintain bone density, but additional interventions are sought to enhance this effect.
Creatine’s potential role in bone health is supported by multiple mechanisms. Osteoblasts (bone-building cells) are metabolically active and rely on the creatine kinase system for energy.
Additionally, creatine’s ability to enhance muscle strength increases mechanical loading on bones, which stimulates bone formation.
Smith-Ryan et al. (2021) highlighted bone health as an emerging area of creatine research in women (Smith-Ryan et al., 2021) .
Study Design
- Type: Randomized, double-blind, placebo-controlled trial
- Participants: Postmenopausal women (mean age approximately 57 years)
- Intervention: 0.1 g/kg/day creatine monohydrate or placebo
- Exercise: Supervised resistance training 3 times per week
- Duration: 12 months
- Primary outcome: Bone mineral density measured by DXA at femoral neck, lumbar spine, and total hip
Key Findings
1. Femoral neck bone density preserved
The creatine group maintained bone mineral density at the femoral neck over 12 months, while the placebo group showed the expected age-related decline.
This is clinically significant because femoral neck fractures are among the most serious consequences of osteoporosis.
2. Muscle strength improvements enhanced
Consistent with established creatine research, the creatine group showed greater improvements in muscle strength compared to placebo.
Stronger muscles apply greater mechanical force to bones during weight-bearing activities.
3. Safe and well tolerated
No significant adverse effects were reported.
Kidney function, liver function, and all monitored health markers remained within normal ranges throughout the 12-month study.
Practical Implications
- Creatine supports bone health in women: Postmenopausal women doing resistance training may benefit from adding creatine to protect bone density
- Affordable osteoporosis intervention: Creatine monohydrate is significantly cheaper than many pharmaceutical osteoporosis treatments
- Dual benefit — muscle and bone: Creatine simultaneously enhances muscle strength and supports bone density
- Long-term safety confirmed: 12 months of daily supplementation produced no safety concerns as supported by broader evidence (Kreider et al., 2017)
Malaysian Relevance
Osteoporosis affects a significant proportion of postmenopausal Malaysian women.
Malaysian women tend to have smaller bone frames and lower peak bone mass compared to Western populations, potentially increasing fracture risk.
Creatine supplementation at approximately RM 30-50 per month represents an affordable, safe strategy to complement weight-bearing exercise and adequate calcium and vitamin D intake.
The findings from Forbes et al. on creatine’s benefits in older adults further support this application (Chilibeck et al., 2017) .
Limitations
- Single study — more RCTs are needed to confirm the bone density findings
- Effects observed primarily at the femoral neck, not consistently at other skeletal sites
- All participants were engaged in resistance training, making it unclear whether creatine alone would produce similar bone effects
- Results may not generalize to all ethnicities
Full Citation
Chilibeck PD, Candow DG, Landeryou T, Kaviani M, Paus-Jenssen L. Effects of creatine and resistance training on bone health in postmenopausal women. Medicine and Science in Sports and Exercise.
2015;47(8):1587-1595. doi:10.1249/MSS.0000000000000571
Where This Fits in the Evidence
Chilibeck and colleagues’ trial is one of the few to take creatine’s bone claims out of the realm of mechanism and into a year-long randomised, double-blind test in the population that needs it most. Where earlier reviews could only argue that stronger muscles should load bone more, this study showed the creatine group holding femoral-neck density steady while placebo declined — a concrete result at a site where fractures are most dangerous. The caveats are real: the benefit was clearest at the femoral neck rather than across every skeletal site, and because every participant also resistance-trained, the trial cannot say what creatine would do for bone without exercise. It is best read as the strongest single signal so far that creatine can support postmenopausal bone, awaiting replication. For the wider evidence base, see our research library.
Sources & References
This article is based on the RCT by Chilibeck et al. and contextualized with Smith-Ryan et al. (2021), Chilibeck et al. (2017), and Kreider et al. (2017).
All citations reference PubMed-indexed publications.